What is the general mechanism by which ATTR develops?

Mutations cause increased production of transthyretin in the liver

Mutations break the TTR tetramers into misfolded monomers that clump into fibrils and stiffen ventricular walls, impairing filling

In ATTR, the problem starts with transthyretin becoming unstable due to mutations. This destabilizes the normal tetramer, causing it to fall apart into misfolded monomers. Those monomers can aggregate into insoluble amyloid fibrils that deposit in the heart tissue, particularly in the walls of the ventricles. As these deposits accumulate, the myocardium becomes infiltrated and stiff, leading to diastolic dysfunction and a restrictive form of cardiomyopathy. The disease mechanism is driven by abnormal protein folding and extracellular deposition, not by simply making more transthyretin or by autoimmune destruction.

Transthyretin remains as stable tetramers and deposits only on the liver

ATTR results from autoimmune destruction of cardiac tissue

Want more questions?

All options are one-time payments.

$25.99

30 day premium pass

All the basics to get you started

  • Ad-free experience
  • View your previous attempt history
  • Mobile app access
  • In-depth explanations
  • 30 day premium pass access
$59.99 $171.99 usd

6 month DELUXE pass (most popular)

Everything with the 30 day premium pass FOR 6 MONTHS! & the ultimate digital PDF study guide (BONUS)

  • Everything included in the premium pass
  • $171.99 usd value for $59.99! You save $106!
  • + Access to the ultimate digital PDF study guide
  • + 6 months of premium pass access
  • + Priority support
$15.99 $24.99

Ultimate digital PDF study guide

For those that prefer a more traditional form of learning

  • Available for instant download
  • Available offline
  • Hundreds of practice multiple choice questions
  • Comprehensive content
  • Detailed explanations
Image Description
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy